mmui mmui mmui mmui mmui mmui mmui
,ABRAMS' CLINICAL DRUG THERAPY: RATIONALES FOR NURSING PRACTICE
mmui mmui mmui mmui mmui mmui mmui
, ABRAMS' CLINICAL DRUG THERAPY: RATIONALES FOR NURSING PRACTICE
mmui mmui mmui mmui mmui mmui mmui
GRADESBOOST.COM
Chapter 1, The Foundation of Pharmacology: Quality and Safety
mm mm mm mm mm mm mm mm
1. A woman diagnosed with obsessive–compulsive disorder has been prescribed
mm mm mm mm mm mm mm mm
oralparoxetine hydrochloride. What is the expected effect for this
mm m mm mm mm mm mm mm mm mm
prescription?
mm
A. Curative effect on symptoms mm mm mm
B. Systemic effect on symptoms mm mm mm
C. Local effect on symptoms mm mm mm
D. Parenteral effect on symptoms mm mm mm
ANS: B m m
Rationale: Drugs that produce systemic effects are taken into the body, circulated
mm mm mm mm mm mm mm mm mm mm mm
through the bloodstream to their sites of action in various body tissues, and
mm mm mm mm mm mm mm mm mm mm mm mm mm
eventually eliminated from the body. Curative agents are given to cure a disease
mm mm mm mm mm mm mm mm mm mm mm mm mm
process. In this case, paroxetine hydrochloride will control the symptoms but not
mm mm mm mm mm mm mm mm mm mm mm mm
cure the disorder. Drugs with local effects,such as sunscreen and local anesthetics,
G R A D E S B O O S T . C O
mm mm mm mm mm mm mm m mm mm mm mm mm
mmui
act mainly at the site of application. Paroxetine hydrochloride is not administered
mm mm mm mm mm mm mm mm mm mm mm mm
parenterally. Parenteral agents are administered subcutaneously, intramuscularly, or
mmui
mm mm mm mm mm mm mm mm
intravenously.
mm
mmui
mmui
PTS: 1 REF: p. 3, Introduction OBJ: 1 mm mm
mmui
NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral
m m mm mm mm mm mm mm
TherapiesTOP: Chapter: 1: The Foundation of Pharmacology: Quality and
mmui
mm m mm mm mm mm mm mm mm
Safety
mm
mmui
KEY: Integrated Process: Nursing Process
m m mm mm mm
mmui
BLM: Cognitive Level: Understand
m m NOT: Multiple Choice mm mm m m mm
mmui
2. A client has been prescribed an antibiotic. This medication is a naturally occurring
mmui
mm mm mm mm mm mm mm mm mm mm mm mm
substance that has been cheG
mRicA
alDlyEm
SoBdOifOieSd.TWhaOt M
.C is another name for this type of
mmui
mm mm mm mm mm mm mm mm mm mm mm
medication?
mm
mmui
A. Synthetic drug mm
B. Semisynthetic drug
mmui
M
mm
mmui
C. Biotechnology drug mm
D. Prototype drug mm
ANS: B m m
Rationale: Semisynthetic drugs (e.g., many antibiotics) are naturally occurring
mm mm mm mm mm mm mm mm
substances that have been chemically modified. Synthetic drugs are more standardized
mm mm mm mm mm mm mm mm mm mm mm
in their chemicalcharacteristics, more consistent in their effects, and less likely to
mm mm mm m mm mm mm mm mm mm mm mm mm
produce allergic reactions. Biotechnology drugs involve manipulating DNA and RNA
mm mm mm mm mm mm mm mm mm mm
and recombining genes into hybrid molecules that can be inserted into living
mm mm mm mm mm mm mm mm mm mm mm mm
organisms. Prototype drugs are the first drug of a particular group to be developed.
mm mm mm mm mm mm mm mm mm mm mm mm mm mm
PTS: 1 REF: p. 3, Drug Sources OBJ: 1 mm mm mm
NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral
m m mm mm mm mm mm mm
TherapiesTOP: Chapter: 1: The Foundation of Pharmacology: Quality and
mm m mm mm mm mm mm mm mm
Safety
mm
KEY: Integrated Process: Nursing Process
m m mm mm mm
BLM: Cognitive Level: Understand
m m NOT: Multiple Choice mm mm m m mm
3. Which classification applies to morphine?
mm mm mm mm
ABRAMS' CLINICAL DRUG THERAPY: RATIONALES FOR NURSING PRACTICE
mm mm mm mm mm mm mm
, ABRAMS' CLINICAL DRUG THERAPY: RATIONALES FOR NURSING PRACTICE
mmui mmui mmui mmui mmui mmui mmui
A. Central nervous system depressant
mm mm mm
B. Central nervous system stimulant
mm mm mm
ABRAMS' CLINICAL DRUG THERAPY: RATIONALES FOR NURSING PRACTICE
mm mm mm mm mm mm mm